Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Anthera Pharmaceuticals Inc (ANTH) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Anthera Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1316175.
Total stock buying since 2014: $17,986.
Total stock sales since 2014: $100,647.
Total stock option exercises since 2014: $78,493.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2017 | 13,550 | $17,986 | 0 | $0 | 10,400 | $14,892 |
| 2016 | 0 | $0 | 0 | $0 | 5,008 | $10,416 |
| 2015 | 0 | $0 | 18,705 | $100,647 | 22,500 | $49,025 |
| 2014 | 0 | $0 | 0 | $0 | 2,000 | $4,160 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2017-09 | 13,550 | $17,986 | 0 | $0 | 10,400 | $14,892 |
| 2016-09 | 0 | $0 | 0 | $0 | 5,008 | $10,416 |
| 2015-12 | 0 | $0 | 0 | $0 | 10,000 | $28,900 |
| 2015-11 | 0 | $0 | 17,500 | $93,237 | 12,500 | $20,125 |
| 2015-10 | 0 | $0 | 1,205 | $7,410 | 0 | $0 |
| 2014-06 | 0 | $0 | 0 | $0 | 2,000 | $4,160 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-09-20 | Thompson John Craig (President & CEO) | Buy | 8,550 | 1.32 | 11,286 |
| 2017-09-07 | Thompson John Craig (President & CEO) | Option Ex | 10,400 | 1.43 | 14,892 |
| 2017-09-07 | Truex Paul F | Buy | 5,000 | 1.34 | 6,700 |
| 2016-09-20 | Truex Paul F (Chief Executive Officer) | Option Ex | 5,008 | 2.08 | 10,416 |
| 2015-12-23 | Mueller Brian | Option Ex | 10,000 | 2.89 | 28,900 |
| 2015-11-13 | Hislop Colin (Chief Medical Officer) | Sale | 12,500 | 5.31 | 66,337 |
| 2015-11-13 | Hislop Colin (Chief Medical Officer) | Option Ex | 12,500 | 1.61 | 20,125 |
| 2015-11-11 | Hislop Colin (Chief Medical Officer) | Sale | 5,000 | 5.38 | 26,900 |
| 2015-10-12 | Odink Debra (Chief Technology Officer) | Sale | 1,205 | 6.15 | 7,410 |
| 2014-06-30 | Truex Paul F (President and CEO) | Option Ex | 2,000 | 2.08 | 4,160 |
Insider trading activities including stock purchases, stock sales, and option exercises of ANTH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Anthera Pharmaceuticals Inc (symbol ANTH, CIK number 1316175) see the Securities and Exchange Commission (SEC) website.